SCHEMBL7622112

SCHEMBL7622112

CCCCc1nc2cccnc2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.72

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 5/20 0.72
AGTR2 P50052 5/20 0.72
ENPP2 Q13822 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29486817 1.00 AGTR1 (0.72) AGTR1AGTR2ENPP2
Hydrochloric Acid SCHEMBL7841670 0.99 AGTR1 (0.71) AGTR1AGTR2ENPP2
SCHEMBL9312828 0.97 AGTR1 (0.68) AGTR1AGTR2ENPP2
SCHEMBL8972057 0.94 AGTR1 (0.71) AGTR1AGTR2
SCHEMBL8972068 0.91 AGTR1 (0.60) AGTR1AGTR2
SCHEMBL8972164 0.91 AGTR1 (0.60) AGTR1AGTR2ENPP2
SCHEMBL8972529 0.91 AGTR1 (0.62) AGTR1AGTR2ENPP2
SCHEMBL9851416 0.90 AGTR1 (0.61) AGTR1AGTR2ENPP2
SCHEMBL9853668 0.89 AGTR1 (0.57) AGTR1AGTR2
SCHEMBL9851484 0.89 AGTR1 (0.56) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6448280-B1 SUCH AS 2-BUTYL-4-CHLORO-5-HYDROXYMETHYL-1-((2'-(1H-TETRAZOL-5-YL) IPHENYL-4-YL)ME THYL)IMIDAZOLE; ZENECA LIMITED (GB) 2002-09-10 US claimed
EP-0636027-A1 ANGIOTENSIN II ANTAGONISTS AGAINST DISORDERS ASSOCIATED WITH IMPAIRED NEURONAL CONDUCTION VELOCITY, ESPECIALLY DIABETIC NEUROPATHY ZENECA LIMITED (GB) 1995-02-01 EP claimed
US-5334718-A Decyclizing a phenyl or a pyridyl or pyrimidyl group by reacting with a base to get angiotension antagonist ZENECA LIMITED (GB) 1994-08-02 US claimed
EP-0399731-B1 Azaindenes ZENECA LTD (GB) 1993-12-08 EP claimed
WO-1993020816-A1 ANGIOTENSIN II ANTAGONISTS AGAINST DISORDERS ASSOCIATED WITH IMPAIRED NEURONAL CONDUCTION VELOCITY, ESPECIALLY DIABETIC NEUROPATHY ZENECA LIMITED (GB) 1993-10-28 WO claimed
EP-0554098-A2 Process for the preparation of imidazo 4,5-b pyridine derivatives ZENECA LIMITED (GB) 1993-08-04 EP claimed
EP-0434038-A1 Fused imidazole derivatives, their production and use Takeda Chemical Industries, Ltd. (JP) 1991-06-26 EP claimed
EP-0426021-A1 Condensed imidazole derivatives and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-05-08 EP claimed
EP-0415886-A2 Aza compounds CIBA-GEIGY AG (CH) 1991-03-06 EP claimed
JP-3005480-A None JP disclosed
JP-3188076-A None JP disclosed
US-6448280-B1 SUCH AS 2-BUTYL-4-CHLORO-5-HYDROXYMETHYL-1-((2'-(1H-TETRAZOL-5-YL) IPHENYL-4-YL)ME THYL)IMIDAZOLE; ZENECA LIMITED (GB) 2002-09-10 US disclosed
US-5661158-A HYPOTENSIVE AGENTS, ANTICHOLESTEROL AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-08-26 US disclosed
US-5506238-A HYPOTENSIVE AGENT EISAI CO., LTD. (JP) 1996-04-09 US disclosed
EP-0554098-A2 Process for the preparation of imidazo 4,5-b pyridine derivatives ZENECA LIMITED (GB) 1993-08-04 EP disclosed
JP-H03188076-A CONDENSED IMIDAZOLE DERIVATIVE AND PRODUCTION THEREOF FUJISAWA PHARMACEUT CO LTD 1991-08-16 JP disclosed
EP-0426021-A1 Condensed imidazole derivatives and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-05-08 EP disclosed
EP-0420237-A1 Biphenylmethane derivative, the use of it and pharmacological compositions containing same Eisai Co., Ltd. (JP) 1991-04-03 EP disclosed
EP-0415886-A2 Aza compounds CIBA-GEIGY AG (CH) 1991-03-06 EP disclosed
JP-H035480-A AZAINDENE, ITS PRODUCTION, THERAPEUTIC AGENT OF HYPERTENSION AND CONGESTIVE HEART DISEASE CONTAINING SUCH AZAINDENE AND INTERMEDIATE IMPERIAL CHEM IND PLC <ICI> 1991-01-11 JP disclosed